Meeting
2018 ASCO Annual Meeting
Novel platform for monitoring bladder cancer recurrence using expression analysis of small non-coding RNAs.
Authors
Ilija Aleksic
Albany Medical College, Albany, NY
Ilija Aleksic , Winnie Wang , Tucker Conklin , Igor Sorokin , Hugh A.G. Fisher , Ronald P. Kaufman Jr., Badar Mian , Barry Kogan , Brian McNeil , Andrew Winer , Raavi Gupta , A. Gregory DiRienzo , Martin Tenniswood
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Molecular Diagnostics and Imaging
Citation
J Clin Oncol 36, 2018 (suppl; abstr 12070)
DOI
10.1200/JCO.2018.36.15_suppl.12070
Abstract #
12070
Poster Bd #
183
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Derivation of gene expression classifiers for the non-invasive detection of bladder cancer in the hematuria and recurrence surveillance populations.
First Author: Karen B. Chapman
Poster
2023 ASCO Annual Meeting
An in-progress phase 2 window of opportunity (WOO) trial of targeted therapy with erdafitinib for patients with recurrent FGFR3-altered non–muscle-invasive bladder cancer (NMIBC).
First Author: Neeta DSouza
Poster
2023 ASCO Genitourinary Cancers Symposium
Comparison of urine cell-free DNA with blood-based screening for detection of bladder cancer.
First Author: Tyler F. Stewart
Poster
2022 ASCO Genitourinary Cancers Symposium
Comprehensive genomic profiling of urine DNA for urothelial carcinoma detection and risk prediction.
First Author: Keyan Salari